Literature DB >> 7172949

Subcutaneous lateral internal sphincterotomy for chronic fissure-in-ano.

T S Ravikumar, S Sridhar, R N Rao.   

Abstract

The results of subcutaneous lateral internal sphincterotomy for chronic fissure-in-ano were analyzed in a series of 60 patients operated upon over a period of two years. Immediate relief from pain with painless first bowel movement was accomplished in 97 per cent of the patients with very low morbidity rates. All patients were treated on an outpatient basis and had a minimum follow-up of two years without any recurrences. The incidence of sphincter dysfunction is very low and is usually only temporary.

Entities:  

Mesh:

Year:  1982        PMID: 7172949     DOI: 10.1007/bf02553316

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  4 in total

1.  Topical 0.5% nifedipine vs. lateral internal sphincterotomy for the treatment of chronic anal fissure: long-term follow-up.

Authors:  Panagiotis Katsinelos; Basilios Papaziogas; Ioannis Koutelidakis; George Paroutoglou; Stavros Dimiropoulos; Anastasios Souparis; Konstantinos Atmatzidis
Journal:  Int J Colorectal Dis       Date:  2005-08-10       Impact factor: 2.571

2.  Anal manometry in patients with fissure-in-ano before and after internal sphincterotomy.

Authors:  E Xynos; A Tzortzinis; E Chrysos; G Tzovaras; J S Vassilakis
Journal:  Int J Colorectal Dis       Date:  1993-09       Impact factor: 2.571

3.  Anal fissure: correlation between symptoms and manometry before and after surgery.

Authors:  M Melange; J F Colin; T Van Wymersch; R Vanheuverzwyn
Journal:  Int J Colorectal Dis       Date:  1992-06       Impact factor: 2.571

4.  Comparative study of conventional lateral internal sphincterotomy, V-Y anoplasty, and tailored lateral internal sphincterotomy with V-Y anoplasty in the treatment of chronic anal fissure.

Authors:  Alaa Magdy; Ayman El Nakeeb; El Yamani Fouda; Mohamed Youssef; Mohamed Farid
Journal:  J Gastrointest Surg       Date:  2012-08-07       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.